Serum level of angiogenin-directed IgM antibodies as a biomarker of response to osteosarcoma therapy Jan. 27, 2011
Mapatumumab/sorafenib combination is safe in patients with advanced HCC and chronic hepatitis Jan. 26, 2011
RSS